Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Hicks

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Biopharmaceutics & Drug Disposition|January 1, 1984
Bioavailability studies with etodolac in dogs and manM Kraml, L Cosyns, D R Hicks, et al.
Clinical Pharmacology and Therapeutics|March 1, 1994
Concomitant etodolac affects neither the unbound clearance nor the pharmacologic effect of warfarinJ C Ermer, D R Hicks, S C Wheeler, et al.
Clinical Chemistry|June 28, 2001
HPLC assay with ultraviolet detection for therapeutic drug monitoring of sirolimusD C French, M Saltzgueber, D R Hicks, et al.
Journal of Clinical Pharmacology|March 20, 1998
Pharmacokinetics and effect of food on the bioavailability of orally administered venlafaxineS M Troy, V P Parker, D R Hicks, et al.
Journal of Clinical Pharmacology|February 1, 1996
Pharmacokinetic interaction between multiple-dose venlafaxine and single-dose lithiumS M Troy, V D Parker, D R Hicks, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1985
Metabolic disposition and pharmacokinetics of the aldose reductase inhibitor tolrestat in rats, dogs, and monkeysM N Cayen, D R Hicks, E S Ferdinandi, et al.
The Annals of Pharmacotherapy|April 1, 1997
Effects of age and gender on the pharmacokinetics of bromfenac in healthy volunteersJ P Boni, S A DeCleene, W H Cevallos, et al.
The Journal of Infectious Diseases|April 1, 1987
Detection of human T cell leukemia virus type I and human immunodeficiency virus in cultured lymphocytes of a Zairian man with AIDSJ P Getchell, J L Heath, D R Hicks, et al.
Journal of Clinical Microbiology|April 1, 1986
Continuous production of a cytopathic human T-lymphotropic virus in a permissive neoplastic T-cell lineJ P Getchell, J L Heath, D R Hicks, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 1, 1986
The metabolic disposition of acifran, a new antihyperlipidemic agent, in rats and dogsM N Cayen, R Gonzalez, E S Ferdinandi, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Biopharmaceutics & Drug Disposition|January 1, 1984
Bioavailability studies with etodolac in dogs and manM Kraml, L Cosyns, D R Hicks, et al.
Clinical Pharmacology and Therapeutics|March 1, 1994
Concomitant etodolac affects neither the unbound clearance nor the pharmacologic effect of warfarinJ C Ermer, D R Hicks, S C Wheeler, et al.
Clinical Chemistry|June 28, 2001
HPLC assay with ultraviolet detection for therapeutic drug monitoring of sirolimusD C French, M Saltzgueber, D R Hicks, et al.
Journal of Clinical Pharmacology|March 20, 1998
Pharmacokinetics and effect of food on the bioavailability of orally administered venlafaxineS M Troy, V P Parker, D R Hicks, et al.
Journal of Clinical Pharmacology|February 1, 1996
Pharmacokinetic interaction between multiple-dose venlafaxine and single-dose lithiumS M Troy, V D Parker, D R Hicks, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1985
Metabolic disposition and pharmacokinetics of the aldose reductase inhibitor tolrestat in rats, dogs, and monkeysM N Cayen, D R Hicks, E S Ferdinandi, et al.
The Annals of Pharmacotherapy|April 1, 1997
Effects of age and gender on the pharmacokinetics of bromfenac in healthy volunteersJ P Boni, S A DeCleene, W H Cevallos, et al.
The Journal of Infectious Diseases|April 1, 1987
Detection of human T cell leukemia virus type I and human immunodeficiency virus in cultured lymphocytes of a Zairian man with AIDSJ P Getchell, J L Heath, D R Hicks, et al.
Journal of Clinical Microbiology|April 1, 1986
Continuous production of a cytopathic human T-lymphotropic virus in a permissive neoplastic T-cell lineJ P Getchell, J L Heath, D R Hicks, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|March 1, 1986
The metabolic disposition of acifran, a new antihyperlipidemic agent, in rats and dogsM N Cayen, R Gonzalez, E S Ferdinandi, et al.
Pageof 3